These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15273104)

  • 1. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
    Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
    Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of azasterols as anti-parasitics.
    Gros L; Lorente SO; Jimenez CJ; Yardley V; Rattray L; Wharton H; Little S; Croft SL; Ruiz-Perez LM; Gonzalez-Pacanowska D; Gilbert IH
    J Med Chem; 2006 Oct; 49(20):6094-103. PubMed ID: 17004723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New azasterols against Trypanosoma brucei: role of 24-sterol methyltransferase in inhibitor action.
    Gros L; Castillo-Acosta VM; Jiménez Jiménez C; Sealey-Cardona M; Vargas S; Manuel Estévez A; Yardley V; Rattray L; Croft SL; Ruiz-Perez LM; Urbina JA; Gilbert IH; González-Pacanowska D
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2595-601. PubMed ID: 16870747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR studies on azasterols as potential anti-trypanosomal and anti-leishmanial agents.
    Gigante F; Kaiser M; Brun R; Gilbert IH
    Bioorg Med Chem; 2009 Aug; 17(16):5950-61. PubMed ID: 19620005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of transition-state analogues of sterol 24-methyl transferase as potential anti-parasitics.
    Lorente SO; Jimenez CJ; Gros L; Yardley V; de Luca-Fradley K; Croft SL; A Urbina J; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
    Bioorg Med Chem; 2005 Sep; 13(18):5435-53. PubMed ID: 16046134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruzi.
    Magaraci F; Jimenez CJ; Rodrigues C; Rodrigues JC; Braga MV; Yardley V; de Luca-Fradley K; Croft SL; de Souza W; Ruiz-Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
    J Med Chem; 2003 Oct; 46(22):4714-27. PubMed ID: 14561091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.
    Chowdhury SR; Kumar A; Godinho JLP; De Macedo Silva ST; Zuma AA; Saha S; Kumari N; Rodrigues JCF; Sundar S; Dujardin JC; Roy S; De Souza W; Mukhopadhyay S; Majumder HK
    Biochem Pharmacol; 2017 Aug; 138():19-30. PubMed ID: 28483460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies.
    Tasdemir D; Kaiser M; Brun R; Yardley V; Schmidt TJ; Tosun F; Rüedi P
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1352-64. PubMed ID: 16569852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
    Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R
    Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
    da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
    Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crovirin, a snake venom cysteine-rich secretory protein (CRISP) with promising activity against Trypanosomes and Leishmania.
    Adade CM; Carvalho AL; Tomaz MA; Costa TF; Godinho JL; Melo PA; Lima AP; Rodrigues JC; Zingali RB; Souto-Padrón T
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3252. PubMed ID: 25330220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLS-Prediction and Confirmation of Hydrojuglone Glucoside as the Antitrypanosomal Constituent of Juglans Spp.
    Ellendorff T; Brun R; Kaiser M; Sendker J; Schmidt TJ
    Molecules; 2015 May; 20(6):10082-94. PubMed ID: 26035104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
    Lepesheva GI; Waterman MR
    Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.
    Lowe G; Droz AS; Vilaivan T; Weaver GW; Tweedale L; Pratt JM; Rock P; Yardley V; Croft SL
    J Med Chem; 1999 Mar; 42(6):999-1006. PubMed ID: 10090783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiprotozoal glutathione derivatives with flagellar membrane binding activity against T. brucei rhodesiense.
    Daunes S; Yardley V; Croft SL; D'Silva C
    Bioorg Med Chem; 2017 Feb; 25(4):1329-1340. PubMed ID: 28131508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
    Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
    Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
    Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
    Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.